Skip to main content
. 2018 Apr 17;9(29):20539–20554. doi: 10.18632/oncotarget.24993

Table 2. Immunophenotypic characteristics and serum molecular markers and auto-antibodies of the patients.

Neu Lymph NLR CRP ESR LDH/N
Overall 3650
(278,2)
1571
(118,4)
2,609
(0,22)
2,434
(0,4)
68 (5.3) 1,481
(0,16)
Wt-k-ras 3456
(507,9)
1581
(41,7)
2,512
(0,45)
1,832
(0,5)
56,5 (6.8) 1,365
(0,26)
Mut-k-ras 3939
(368,7)
1636
(171,7)
2,748
(0,3)
3,104
(0,8)
68 (7.8) 1,601
(0,2)
CEA c-ANCA p-ANCA ENA
Overall 122,5
(211.8)
0,921
(0,1)
0,688
(0,08)
0,324
(0,04)
Wt-k-ras 180.5
(383.3)
1,086
(0,1)
0,729
(0,21)
0,337
(0,02)
Mut-K-ras 122,5
(127.8)
0,763
(0,08)
0,625
(0,08)
0,326
(0,05)
CD4+ CD8+ Treg Tcm Tem c-NK MDSCs
Overall 40,1 (2,6) 26,9 (1,7) 3,2 (0,44) 6,3 (1,39) 40,3 (3,26) 9.63 (3,36) 3.95 (1,97)
Wt-k-ras 38,2 (1,8) 25,7 (2,1) 3,2 (0,05) 4,7 (0,09) 44,7 (2,2) 7.57 (4,45) 4.47 (1,47)
Mut-K-ras 44,2 (3,3) 29,6 (2,8) 3,5 (0,7) 8,57 (2,67) 37,2 (5,06) 11.7* (4,13) 3.55 (2,1)
*0.030913